Manufacturer or GPO Program year 2025 Source: CMS Open Payments

3B Medical, Inc.

FL, United States

CMS manufacturer 100001341948

Open in the dashboard

General payments

$80,784

1,969 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, 3B Medical, Inc. reported paying $80,784 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $41,697 1,236
2024 General $29,309 495
2023 General $9,779 238

Breakdown

Top recipients General payments · program year 2025
  1. Nathaniel Watson Neurology · Seattle, WA $4,250 3 payments
  2. William Frazier Pulmonary Disease · Canton, MS $3,500 3 payments
  3. Ryne Simpson Pediatric Pulmonology · Birmingham, AL $2,325 2 payments
  4. Bernardo Selim Pulmonary Disease · Rochester, MN $1,725 2 payments
  5. John Coleman Sleep Medicine · Chicago, IL $1,171 2 payments
  6. Nasir Awan Critical Care Medicine · Greenville, SC $295 4 payments
  7. Jennifer Dougherty Physician Assistant, Medical · Lancaster, PA $215 25 payments
  8. Meredith Huguenard Nurse Practitioner · Columbus, OH $179 1 payment
  9. Jay Berland Pulmonary Disease · Lake Success, NY $133 1 payment
  10. Charlene McEvoy Pulmonary Disease · Saint Paul, MN $125 1 payment
Products the payments named General payments · program year 2025
  1. Luna Ventilator, Non-Continuous (Respirator) $41,697 100% · 1,010 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $13,175 32% · 288 practitioners
  2. Neurology Psychiatry & Neurology $4,826 12% · 28 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $3,944 10% · 142 practitioners
  4. Sleep Medicine Internal Medicine $3,216 8% · 54 practitioners
  5. Pediatric Pulmonology Pediatrics $2,732 7% · 15 practitioners

The top 5 of 51 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Washington $4,768 11% · 13 recipients
  2. Mississippi $4,352 10% · 37 recipients
  3. Alabama $3,875 9% · 46 recipients
  4. Texas $2,947 7% · 114 recipients
  5. Georgia $2,924 7% · 64 recipients

The top 5 of 45 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $54,152 1,948 payments
  2. Consulting Fee $24,350 19 payments
  3. Debt forgiveness $1,750 1 payment
  4. Travel and Lodging $532 1 payment
1,969 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record